Opponents of the mandatory screenings raise serious concerns about medical privacy, legal authority, and the potential for misuse. Civil liberties groups have already signaled that they are prepared to challenge the policy in court, arguing that requiring all service members to submit to a test that can reveal sensitive health information—without a clear operational need—violates basic rights. They note that testosterone levels can be affected by factors like race, age, and even time of day, making blanket thresholds arbitrary.
Medical experts caution that mass screenings can lead to unnecessary treatments or stigmatization. In civilian settings, such campaigns are strictly regulated to avoid over-diagnosis. The military's system lacks independent oversight, raising fears that those with low testosterone could be discharged or denied assignments based on inconclusive data. Veterans' organizations have also pointed out that the policy could discourage honest reporting of health issues if service members fear repercussions.
Critics also see the policy as a symptom of a larger fixation by Hegseth on biology and performance. They argue that it diverts attention and resources from more urgent problems, such as aging equipment, recruitment shortages, and mental health support. The $50 million allocated for screenings could have been used to improve barracks, pay, or family services. Instead, the military is spending money on tests that may yield ambiguous results.
Finally, the legal foundation is shaky. Congress has not authorized such a broad medical mandate, and existing regulations protect service members from unnecessary intrusions. Lawmakers from both parties have expressed skepticism, and the Pentagon's ability to enforce the rule is uncertain. As lawsuits loom and implementation begins, the screening mandate threatens to undermine trust between troops and leadership, making it harder to retain experienced personnel.